1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-((trimethylsilyl)ethynyl)pyrimidine-2,4(1H,3H)-dione

Catalog No. :
ACAFXG784
CAS No. :
2260774-98-7
Molecular Formula :
C14H20N2O6Si
Molecular Weight :
340.41

IUPAC Name:1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-((trimethylsilyl)ethynyl)pyrimidine-2,4(1H,3H)-dione

1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-((trimethylsilyl)ethynyl)pyrimidine-2,4(1H,3H)-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$358.00Login to see priceIn stockInquiry
250mg95%$715.00Login to see priceIn stockInquiry
1g95%$1290.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-((trimethylsilyl)ethynyl)pyrimidine-2,4(1H,3H)-dione
IUPAC Name1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-((trimethylsilyl)ethynyl)pyrimidine-2,4(1H,3H)-dione
Molecular FormulaC14H20N2O6Si
Molecular Weight340.41
SMILESC[Si](C)(C)C#CC1=CN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(=O)NC1=O
InChI KeyQWIPJBIGVRYXIM-PRULPYPASA-N
CAS No.2260774-98-7

Synthetic Route by SureRoute

1. ACAFXG784 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACOCUX715 route compound structure diagram
    ACOCUX7151024-99-3 In Stock
  4. Then
  5. ACAFXG784 route product structure diagram
    ACAFXG7842260774-98-7 In Stock
Inquiry

2. ACAFXG784 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFDZA523 route compound structure diagram
    ACFDZA523957-75-5 In Stock
  4. Then
  5. ACAFXG784 route product structure diagram
    ACAFXG7842260774-98-7 In Stock
Inquiry

Comments (0)